Suppr超能文献

p53与线粒体功能障碍:神经退行性疾病的新见解

p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases.

作者信息

Dai Chun-Qiu, Luo Ting-Ting, Luo Shi-Cheng, Wang Jia-Qi, Wang Sheng-Ming, Bai Yun-Hu, Yang Yan-Ling, Wang Ya-Yun

机构信息

Department of Anatomy, Histology and Embryology, K.K. Leung Brain Research Centre, The Fourth Military Medical University, Xi'an, 710032, China.

Department of Neurobiology and Collaborative Innovation Center for Brain Science, School of Basic Medicine, The Fourth Military Medical University, Xi'an, 710032, China.

出版信息

J Bioenerg Biomembr. 2016 Aug;48(4):337-47. doi: 10.1007/s10863-016-9669-5. Epub 2016 Jul 15.

Abstract

Mitochondria are organelles responsible for vital cell functions. p53 is a transcription factor that regulates the DNA stability and cell growth normality. Recent studies revealed that p53 can influence mitochondrial function changing from normal condition to abnormal condition under different stress levels. In normal state, p53 can maintain mitochondrial respiration through transactivation of SCO2. When stress stimuli presents, SCO2 overexpresses and leads to ROS generation. ROS promotes p53 inducing MALM (Mieap-induced accumulation of lysosome-like organelles within mitochondria) to repair dysfunctional mitochondria and MIV (Mieap-induced vacuole) to accomplish damaged mitochondria degradation. If stress or damage is irreversible, p53 will translocate to mitochondria, leading into apoptosis or necrosis. Neurodegenerative diseases including Parkinson's disease, Huntington's disease and Alzheimer's disease are still lack of clear explanations of mechanisms, but more studies have revealed the functional relationship between mitochondria and p53 towards the pathological development of these diseases. In this review, we discuss that p53 plays the vital role in the function of mitochondria in the aspect of pathological change metabolism. We also analyze these diseases with novel targeted treating molecules which are related to p53 and mitochondria, hoping to present novel therapies in future clinic.

摘要

线粒体是负责细胞重要功能的细胞器。p53是一种调节DNA稳定性和细胞生长正常性的转录因子。最近的研究表明,在不同应激水平下,p53可影响线粒体功能从正常状态转变为异常状态。在正常状态下,p53可通过SCO2的反式激活来维持线粒体呼吸。当应激刺激出现时,SCO2过度表达并导致活性氧(ROS)生成。ROS促进p53诱导线粒体相关溶酶体样细胞器堆积(MALM,即Mieap诱导的线粒体内溶酶体样细胞器堆积)以修复功能失调的线粒体,并促进Mieap诱导的空泡(MIV)形成以完成受损线粒体的降解。如果应激或损伤是不可逆的,p53将转位至线粒体,导致细胞凋亡或坏死。包括帕金森病、亨廷顿病和阿尔茨海默病在内的神经退行性疾病的发病机制仍缺乏明确解释,但更多研究揭示了线粒体与p53在这些疾病病理发展过程中的功能关系。在本综述中,我们讨论了p53在病理变化代谢方面的线粒体功能中发挥的关键作用。我们还分析了与p53和线粒体相关的新型靶向治疗分子在这些疾病中的应用,希望能为未来临床提供新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a6/5026713/465a72da9217/10863_2016_9669_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验